Exelixis
EXEL
#1678
Rank
HK$78.89 B
Marketcap
HK$276.25
Share price
1.89%
Change (1 day)
67.00%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company